Fig. 2
Comparative Annual Treatment Costs of Adalimumab vs. Risankizumab for Plaque Psoriasis: A Perspective from Saudi Arabia’s Public Health Sector
Fig. 2 | Cost Effectiveness and Resource Allocation
Comparative Annual Treatment Costs of Adalimumab vs. Risankizumab for Plaque Psoriasis: A Perspective from Saudi Arabia’s Public Health Sector